K. Takagi

发表

Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations

N. Kamatani, T. Igarashi, T. Sugiura, 2008 .

Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations

N. Kamatani, T. Igarashi, T. Sugiura, 2008, Modern rheumatology.

Increased IL-15 production of muscle cells in polymyositis and dermatomyositis.

N. Kamatani, Michinobu Tanaka, M. Harigai, 2002, International immunology.

Single nucleotide polymorphisms of the HIF1A gene are associated with susceptibility to pulmonary arterial hypertension in systemic sclerosis and contribute to SSc‐PAH disease severity

M. Harigai, M. Kawamoto, T. Higuchi, 2020, International journal of rheumatic diseases.

Clinical Manifestations of Adult‐Onset Still's Disease Presenting With Erosive Arthritis: Association With Low Levels of Ferritin and Interleukin‐18

H. Yamanaka, Y. Ota, T. Sugiura, 2014, Arthritis care & research.

Single nucleotide polymorphisms of CD244 gene predispose to renal and neuropsychiatric manifestations with systemic lupus erythematosus

K. Ikari, H. Yamanaka, S. Momohara, 2010, Modern rheumatology.

Single nucleotide polymorphisms of CD244 gene predispose to renal and neuropsychiatric manifestations with systemic lupus erythematosus

K. Ikari, H. Yamanaka, S. Momohara, 2010, Modern rheumatology.

Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus

N. Kamatani, T. Sugiura, Y. Katsumata, 2007, Arthritis research & therapy.

Capillary abnormalities observed by nailfold video-capillaroscopy in Japanese patients with systemic sclerosis

H. Yamanaka, Y. Katsumata, T. Higuchi, 2018, Modern rheumatology.

Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis.

H. Yamanaka, Y. Ota, M. Kuwana, 2010, Rheumatology.

Brief report: Association of HLA-DRB1*0101/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population.

H. Yamanaka, Y. Ota, M. Kuwana, 2012, Arthritis and rheumatism.

Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up

H. Yamanaka, Y. Ota, T. Gono, 2011, Modern rheumatology.

Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.

Miki Nakagawa, N. Kamatani, Michinobu Tanaka, 2004, Arthritis and rheumatism.

Immuno-suppressive peptides for a human T cell clone autoreactive to a unique acetylcholine receptor alpha subunit peptide presented by the disease-susceptible HLA-DQ6 in infant-onset myasthenia gravis.

S. Senju, S. Matsushita, Y. Nishimura, 1997, Human immunology.

Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.

N. Kamatani, M. Harigai, T. Sugiura, 2004, Arthritis and rheumatism.

Increased CD40 Expression on Muscle Cells of Polymyositis and Dermatomyositis: Role of CD40-CD40 Ligand Interaction in IL-6, IL-8, IL-15, and Monocyte Chemoattractant Protein-1 Production1

N. Kamatani, M. Harigai, T. Sugiura, 2000, The Journal of Immunology.

Sildenafil attenuates the fibrotic phenotype of skin fibroblasts in patients with systemic sclerosis.

H. Yamanaka, Y. Ota, Y. Katsumata, 2015, Clinical immunology.

Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features

N. Kamatani, M. Harigai, T. Sugiura, 2003, Clinical and experimental immunology.

Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment

H. Yamanaka, Y. Katsumata, I. Masuda, 2019, Arthritis Research & Therapy.

Protein-1 Production IL-15 , and Monocyte Chemoattractant IL-8 , CD 40-CD 40 Ligand Interaction in IL-6 , ofof Polymyositis and Dermatomyositis : Role Increased CD 40 Expression on Muscle Cells and Naoyuki Kamatani

M. Harigai, T. Sugiura, Y. Kawaguchi, 2000 .

Clinical manifestations of neurological involvement in primary Sjögren’s syndrome

H. Yamanaka, Y. Ota, T. Gono, 2011, Clinical Rheumatology.

Activation of the activin A-ALK-Smad pathway in systemic sclerosis.

H. Yamanaka, M. Takagi, Y. Ota, 2011, Journal of autoimmunity.

of Polymyositis and Dermatomyositis: Role Increased CD40 Expression on Muscle Cells

N. Kamatani, M. Harigai, T. Sugiura, 2013 .

Ghrelin attenuates collagen production in lesional fibroblasts from patients with systemic sclerosis.

H. Yamanaka, Y. Ota, T. Gono, 2013, Clinical immunology.

Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40‐CD154 in the phenotype of SSc fibroblasts

N. Kamatani, M. Harigai, T. Sugiura, 2003, European journal of immunology.

Characteristics of Japanese patients with systemic sclerosis complicated with calcinosis

M. Harigai, M. Kawamoto, T. Higuchi, 2021, International journal of rheumatic diseases.

Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.

N. Kamatani, Michinobu Tanaka, M. Harigai, 2002, The Journal of rheumatology.

THU0333 2-CARBA CYCLIC PHOSPHATIDIC ACID (2CCPA) SUPPRESSES PROFIBROTIC ACTIVITY IN SYSTEMIC SCLEROSIS SKIN FIBROBLASTS AND BLEOMYCIN-INDUCED SKIN FIBROSIS IN MICE

H. Yamanaka, Y. Katsumata, I. Masuda, 2019, Poster Presentations.

Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease.

H. Yamanaka, Y. Ota, T. Sugiura, 2010, Rheumatology.

Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome accompanied by Parkinson's disease.

S. Uchiyama, H. Okamoto, K. Ohara, 2007, Internal medicine.

Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.

H. Yamanaka, Y. Ota, M. Kuwana, 2014, Rheumatology.

Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis.

H. Yamanaka, Shinji Sato, Y. Ota, 2012, Rheumatology.

Guillain-Barré syndrome accompanied by central nervous system lupus in a patient with juvenile rheumatoid arthritis

N. Kamatani, H. Nakajima, M. Harigai, 2001, Modern rheumatology.

Mature form of interleukin 18 is expressed in rheumatoid arthritis synovial tissue and contributes to interferon-gamma production by synovial T cells.

N. Kamatani, Michinobu Tanaka, M. Harigai, 2001, The Journal of rheumatology.

A case of relapsing polychondritis with bilateral sensorineural hearing loss and perforation of the nasal septum at the onset

N. Kamatani, I. Masuda, Toru Yamada, 2007, Modern rheumatology.

Modulation of TNF-α Gene Expression by IFN-γ and Pamidronate in Murine Macrophages: Regulation by STAT1-Dependent Pathways1

M. Takagi, H. Shigemitsu, A. Postlethwaite, 2005, The Journal of Immunology.

STAT 1-Dependent Pathways Macrophages : Regulation by and Pamidronate in Murine γ IFN-Gene Expression by α Modulation of TNF

M. Takagi, H. Shigemitsu, A. Postlethwaite, 2005 .

Tumor necrosis factor-alpha (TNF-alpha) converting enzyme contributes to production of TNF-alpha in synovial tissues from patients with rheumatoid arthritis.

N. Kamatani, Michinobu Tanaka, M. Harigai, 2001, The Journal of rheumatology.

Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement.

N. Kamatani, M. Kuwana, T. Satoh, 2007, The Journal of rheumatology.

Modulation of TNF-alpha gene expression by IFN-gamma and pamidronate in murine macrophages: regulation by STAT1-dependent pathways.

M. Takagi, H. Shigemitsu, A. Postlethwaite, 2005, Journal of immunology.

Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in Japan: a review of the literature

T. Horiuchi, C. Kiyohara, M. Washio, 2013, Modern rheumatology.

Urinary free light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis.

Hirotaka Kaneko, Yasushi Kawaguchi, Hisashi Yamanaka, 2013, Rheumatology.

Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin.

N. Kamatani, K. Nishimura, Michinobu Tanaka, 2007, The Journal of rheumatology.

Ghrelin attenuates collagen production in lesional fibroblasts from patients with systemic sclerosis.

H. Yamanaka, Y. Ota, T. Gono, 2013, Clinical immunology.

Association of elevated serum carbohydrate antigen 19-9 levels with extensive interstitial lung disease in patients with systemic sclerosis: A cross-sectional study.

Y. Katsumata, T. Higuchi, K. Takagi, 2023, International journal of rheumatic diseases.

Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model

T. Higuchi, K. Takagi, A. Tochimoto, 2023, Scientific reports.